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Abstract
Background: Although cognitive-behavioral therapy for Unexplained Physical Symptoms (UPS) is effective in secondary
care, studies done in primary care produced implementation problems and conflicting results. We evaluated the
effectiveness of a cognitive-behavioral group training tailored to primary care patients and provided by a secondary
community mental-health service reaching out into primary care.
Methodology/Principal Findings: The effectiveness of this training was explored in a randomized controlled trial. In this
trial, 162 patients with UPS classified as undifferentiated somatoform disorder or as chronic pain disorder were randomized
either to the training or a waiting list. Both lasted 13 weeks. The preservation of the training’s effect was analyzed in non-
randomized follow-ups, for which the waiting group started the training after the waiting period. All patients attended the
training were followed-up after three months and again after one year. The primary outcomes were the physical and the
mental summary scales of the SF-36. Secondary outcomes were the other SF-36-scales and the SCL-90-R. The courses of the
training’s effects in the randomized controlled trial and the follow-ups were analyzed with linear mixed modeling. In the
randomized controlled trial, the training had a significantly positive effect on the quality of life in the physical domain
(Cohen’s d = 0.38;p = .002), but this overall effect was not found in the mental domain. Regarding the secondary outcomes,
the training resulted in reporting an improved physical (Cohen’s d = 0.43;p = 0.01), emotional (Cohen’s d = 0.44;p = .0.01),
and social (Cohen’s d = 0.36;p = 0.01) functioning, less pain and better functioning despite pain (Cohen’s
d = 0.51;p =,0.001), less physical symptoms (Cohen’s d =2.23;p = 0.05) and less sleep difficulties (Cohen’s
d =20.25;p = 0.04) than time in the waiting group. During the non-randomized follow-ups, there were no relapses.
Conclusions/Significance: The cognitive-behavioral group training tailored for UPS in primary care and provided by an
outreaching secondary mental-health service appears to be effective and to broaden the accessibility of treatment for UPS.
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Introduction
The estimated prevalence of Unexplained Physical Symptoms
(UPS) ranges from 18 to 74% in primary care [1,2,3], and from 30
to 52% in secondary care [4,5,6,7]. UPS is more prevalent in
women than in men [7,8,9,10] and women in their forty’s seem to
run a higher risk [2,10]. Other demographic characteristics
seemed not be associated with UPS in a consistent manner. For
example, some studies found lower socioeconomic background to
be associated with UPS [9,10], while others found an association
with having work and a higher education attainment [7]. Patients
with UPS attributed their physical symptoms more to physical
causes than to lifestyle factors in comparison to patients with a
medical diagnosis [7]. Moreover, patients with
UPS are more reluctant than patients with mental disorders to
accept a psychiatric diagnosis for their symptoms [11]. UPS are
associated with more concomitant psychological symptoms, more
impaired functioning and had higher medical utilization than
other patient groups [8,10,12].
Cognitive-behavioral therapy has shown to be most effective for
patients with UPS. It reduces UPS and concomitant psychological
symptoms, improves daily functioning, and reduces financial
expenses [13,14,15] without causing harmful effects [16]. How-
ever, the effect of this treatment has been studied mainly in
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medical subspecialty clinics or mental health centers [13,17,18] –
resources that are not easily accessible to patients [19], either
because their capacity is limited, or because patients refuse to be
referred to the mental-health services [17,20].
To make treatment for UPS more accessible to patients, general
practitioners have been trained to carry out cognitive-behavioral
therapy. However, only two studies have shown effect when this
therapy was provided by general practitioners [21,22]; most other
studies were unable to show any conclusive effect
[23,24,25,26,27,28]. Also, the transfer of this therapy by general
practitioners into routine clinical practice has been hampered by
practical issues at the level of the general practitioner, the patients
and the treatment. At the level of general practitioners, the
implementation was difficult as they hesitated to implement this
treatment for UPS. In a British study [29], 1,934 general
practitioners were invited to be trained in cognitive-behavioral
therapy. Despite the promise of financial compensation, only 70
agreed to participate (3.6%). Those who did participate reported
difficulties in implementing the therapy in their family practice
because of, for example, the limited time available in patient-
physician encounters [30]. At patient’s level, the implementation
was difficult as patients hesitated to disclose psychosocial issues to
their general practitioners [31] and were less satisfied about the
quality of care from their general practitioners than patients with a
medical diagnosis. For example, they felt that the general
practitioner did not take them seriously and took too little time
for them [12,32]. At treatment level, the implementation was
difficult as general practitioners and patients had different
objectives for their encounters: the former aimed to explain and
alleviate symptoms, while the latter hoped to find clinician support
[31,33].
As an alternative to training general practitioners to carry out
cognitive-behavioral therapy for UPS, it might be possible for
professional therapists from a secondary community mental-health
service to make this treatment easily accessible to primary-care
patients. First, however, three problems should be resolved: the
capacity of secondary care should be increased, patients’ refusal to
be referred to mental-health services should be reduced, and
therapists’ and patients’ objectives for treatment encounters should
be aligned.
As a secondary community mental-health service, we ap-
proached these problems as follows. First, to increase capacity, we
organized group treatment instead of individual treatments.
Second, to minimize patients’ refusal to be referred to mental-
health services, we sought close collaboration with medical services
and offered treatment locally at their centers. Moreover, we used a
cognitive-behavioral model which had previously achieved high
acceptance in a secondary medical outpatient clinic [34]. As the
available manuals based on this model were only intended for
individual treatments [35,36,37], we had to write a manual for
group treatment [38].Third, to align the objectives of the
therapists and patients, we tailored the treatment to match
primary-care patients’ objectives for treatment.
Objectives
Our first objective was to evaluate the effectiveness of the
cognitive-behavioral group training tailored to primary care
patients and provided by a secondary community mental-health
service reaching out into primary care. The second aim was to
observe whether the effect of this group training was preserved in a
one-year follow-up period. Our hypotheses were that the group
training could raise the quality of life in patients with UPS, and
that this effect could be preserved during the follow-up.
Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
Ethics
The study was approved by the Erasmus Medical Research
Ethics Committee and was registered in the Dutch Trial Register
(NTR 1609) [39]. A detailed description of the study protocol has
been published elsewhere [40]. Patients in this study gave written
informed consent.
Study design
The effectiveness of the group training was investigated in a
randomized controlled trial. To this end, patients were random-
ized either to the training or a waiting list after they had completed
the baseline measurement (T0). The second measurement (T1)
was made directly after the training (13 weeks), or after the same
period for those on the waiting list.
The preservation of the effect of the group training was
investigated in a non-randomized one-year follow-up. To this end,
patients, who had been randomized to the waiting list and had
waited, started the training after their second measurement (T1).
Patients, who attended the training directly after randomization or
after the waiting period, were followed-up three months after the
end of treatment (T2), and again one year later (T3).
Participants
General practitioners and specialists were asked to refer patients
aged between 18 and 65 whose physical symptoms, according to
their clinical judgment, could not be fully explained by a known
medical condition.
Patients were included if they signed the informed consent, and
if their UPS fulfilled the DSM-IV criteria for an undifferentiated
somatoform disorder or a chronic pain disorder. To verify whether
the UPS fulfilled the criteria for undifferentiated somatoform
disorder or chronic pain disorder, we used the Structured Clinical
Interview for DSM-IV Axis I Disorders (SCID-I) [41], a semi-
structured validated interview for making the major DSM-IV Axis
I diagnoses.
Patients were excluded from the study if poor language skills or
handicaps such as cognitive impairment prevented them from
understanding the training.
Interventions
The intervention is a cognitive-behavioral therapy based on the
consequences model. In Figure 1, the consequences model is drawn
with the solid arrows [42]. In the consequences model, psycholog-
ical and social factors, which are commonly labeled as causes [43],
are labeled as consequences of UPS. UPS (such as abdominal pain)
in itself is seen as a stressful condition about which patients develop
dysfunctional beliefs (such as ‘I have colon cancer’) that produce
cognitive, behavioral, physical, and social consequences. In the
short term, these consequences have beneficial effects, either by
themselves (such as eating easily digestible food to recuperate), or
through interaction with other consequences (such as continuing an
activity to distract oneself from the abdominal pain). In the long
term, however, these consequences might produce self-perpetuating
vicious circles that maintain or aggravate UPS (such as eating less
and less, and continuing an activity beyond one’s physical limits that
leads to more abdominal pain and tiredness). The objective of
treatment based on the consequences model is to alleviate symptoms
[35,37,42].
Group Training for Unexplained Physical Symptoms
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This model was tailored to primary-care patients. The changes
resulting from this tailoring are shown in dotted lines and italics of
Figure 1. They can be summarized in terms of three adjustments:
1.) Adding and starting bottom-up next to top-
down. Our first change was based upon the fact, that, in the
original model, beliefs have a central role. However, the focus on
Figure 1. Tailored consequences model.
doi:10.1371/journal.pone.0042629.g001
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thoughts might not fit the more physically orientated way of
viewing and communicating of patients [7,14,44], and the need to
challenge thoughts in cognitive-behavioral therapy has been
questioned lately [45].
In our tailored version of the consequences model, we therefore
enter the model bottom-up instead of top-down. Herewith, the
consequences rather than the beliefs have a central role. By
changing and reducing the consequences, beliefs are addressed
indirectly, after which the beliefs can still be addressed directly.
2.) Aggravating instead of maintaining reactions. Our
second change was based upon the fact that, in the original model,
the consequences can maintain UPS. In our view, patients might
translate that as personal blame for causing the continuation of
their UPS. This does not match primary-care patients’ hope of
finding clinician support [31,33].
In our tailored version of the consequences model, causes are
consistently labeled as unknown. The consequences therefore
aggravate symptoms rather than maintain UPS. In this way,
patients are relieved from blame not only for the cause and
existence of UPS, but also for its persistence.
3.) Improvement of quality of life instead of symptom
alleviation. Our last change was based upon the fact that, in
the original model, the treatment objective is to alleviate symptoms
[35,37,42]. However, primary-care patients mainly hope to find
clinician support [31,33], followed by improving daily functioning
and coping with UPS [33].
In our tailored version of the consequences model, the
treatment objective is to improve patients’ quality of life not only
by preventing aggravation of symptoms but also by increasing
daily functioning and coping. This expands the opportunities to
support patients’ reactions and makes support independent of
changes in UPS in itself, since its causes are explicitly labeled as
unknown.
Based on this tailored cognitive-behavioral model, a manual was
developed for a group training called ‘Coping with the
consequences of unexplained physical symptoms’ [38]. This
training consists of 13 weekly two-hour sessions organized in local
medical settings. Table 1 shows the cognitive-behavioral tech-
niques used in each session.
The control intervention was a waiting list. The waiting period
was as long as the period of the intervention.
Outcomes
To measure improvement in quality of life, we used the 36-item
Medical Outcomes Study Short-Form General Health Survey (SF-
36), a validated and reliable self-report questionnaire with 36
questions and fixed-response alternatives for assessing functional
health and well-being over the past four weeks [46]. The responses
are converted into eight multi-item scales (0–100): ‘Physical
functioning’, ‘Role functioning physical’, ‘Bodily pain’, ‘General
health’, ‘Vitality’, ‘Social functioning’, ‘Role functioning emotion-
al’, and ‘Mental health’. These scales can be summarized into the
‘Physical component summary’, in which the first four of the
above eight scales are weighted most heavily; and into the ‘Mental
component summary’, in which the last four of the above eight
scales are weighted most heavily [47]. These summaries are
transformed into T-scores with a mean of 50 and standard
deviation of 10. Higher scores on SF-36 scales indicate a better
quality of life.
To measure the intensity of a broad range of psychological
problems and psychopathology symptoms, we used the revised 90-
item Symptom Checklist (SCL-90-R), a validated and reliable self-
report questionnaire with 90 questions and fixed response
alternatives for assessing the intensity of symptoms over the past
week [48]. The responses are summed up in eight multi-item
scales: ‘Phobic anxiety’, ‘Anxiety’, ‘Depression’, ‘Somatization’,
‘Obsessive-compulsiveness’, ‘Interpersonal sensitivity’, ‘Hostility’,
and ‘Sleep difficulties’. These scales can be summarized in the
‘Global severity index’. Higher scores on SCL-90 scales indicate a
higher number or more severe symptoms.
Primary outcome measures were the ‘Physical component
summary’ and the ‘Mental component summary’ of the SF-36.
Secondary outcome measures were the individual SF-36 scales and
the SCL-90-R scales.
For the SF-36, the manual provides an algorithm to compute the
scale scores with a single norm for maximum tolerated percentage of
missing items. In this algorithm, a SF-36-scale was only computed, if
a patient had completed at least 50% of the items belonging to this
SF-36 scale. If this was the case, the patient’s available items
belonging to the same scale were added up and the resulting sum
was divided by the number of available scale items of the same
patient. If the number of missing items on a SF-36 scale exceeded
the 50% percentages, the data for this scale remained missing.
For the SCL-90-R, the manual provides an algorithm to
compute the scales with a norm for the maximum tolerated
number of missing items. For the scale ‘Sleep difficulties’, the
maximum tolerated number of missing items is one; for the other
scales, this maximum is two. By this, the maximum tolerated
percentage of missing items of the scales ranges from 67% to 98%.
We chose to set the maximum tolerated percentage of missing
items for all scales on 75%. In the resulting algorithm, a SCL-90-R
scale was only then computed, if a patient had completed at least
75% of the items belonging to this SCL-90-R scale. If this was the
case, the patient’s available items belonging to the same SCL-90-R
scale were added up and the resulting sum was divided by the
number of available scale items of the same patient. If the number
of missing items on a SCL-90-R scale exceeded this 75%
percentage, the data for this scale remained missing.
Sample size
The sample size required was calculated by power analysis. For
power analysis, we applied SPSS version 17 and the mixed-model
ANOVA procedure described by Aberson [49]. The repeated-
measurement correlation required for the power analysis was
estimated on basis of the SF-36 manual [47]. In the manual, a two-
weeks test-retest correlation of 0.80 was reported for the SF-36
summary scale ‘Mental component summary’ and 0.89 for the
‘Physical component summary’. Taking into account that a
reduction of these correlations should be expected as the time
period between two measurements in our study was longer and
included the intervention, the correlation was estimated at 0.75.
The effect size for the power analysis was estimated at 0.40 based on
a review [14], in which the effect sizes for cognitive-behavioral
treatments in UPS compared to control conditions centered around
.40. These values for correlation and effect size, in combination with
an alpha of 0.05 and a beta of 0.20 led to a required sample size of
51 in each group. Adjusted for a dropout of one third, this resulted
in a total sample size of 153. The presented procedure to estimate
the required sample size deviates from the one described in the
original trial protocol [39], as the original power analysis did not
match the intended and original statistical analysis plan.
Randomization—Sequence generation
Patients were assigned to the training or to the waiting list
according to a computer generated randomization list. This
randomization list was generated just before the start of the next
training for enrolled patients who had completed all baseline
measurements. As each 13-week training followed the previous
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Table 1. The cognitive-behavioral techniques used in each session.
Session Acquaintance
1 Plenary define personal goals for the training
Plenary present the characteristics of own UPS
Session Consequence Cognitive-behavioral technique
2 Physical Psycho-education on physical arousal
Stopping physical arousal and replacing it with abdominal breathing and
relaxation
Behavioral Psycho-education on habits
Stopping potentially harmful habits and replacing them with incompatible
beneficial ones, such as:
-drinking warm herbal tea rather than drinking beer to fall asleep in the evening
-using skin moisturizer rather than scratching to stop a body itch
3 Behavioral Psycho-education on under-activity, over-activity, and the combination of both
Stopping under-activity, over-activity, or the combination from them and
replacing them with scheduling various activities at a feasible pace with short
breaks
Physical Rehearsal: abdominal breathing and relaxation
4 Emotional Psycho-education on the meaning of emotions and on the physical arousal they
cause
Recognizing emotions as an important sign that
-the situation at hand does not correspond with own wishes, needs and
expectations
-the situation asks for change and improvement
Stopping physical arousal of emotions and replacing it with abdominal breathing
and relaxation
Various Rehearsal: abdominal breathing and relaxation, and pacing activities
5 Beliefs Psycho-education on beliefs
Stopping dysfunctional beliefs and replacing them with facts and helpful beliefs
using Ellis’ ABC scheme
Various Rehearsal: abdominal breathing and relaxation and pacing activities
6 Physical Psycho-education on physical fitness
Improving physical fitness by doing daily a low-cardiac physical activity, extending
it by a minute per day, to a target of 60 minutes twice daily
Various Rehearsal: abdominal breathing and relaxation, and pacing activities
7 Cognitive Psycho-education on information processing
Stopping dysfunctional information processing and replacing it with a functional
information processing
Social Summarizing all consequences of own UPS in a scheme and discussing this
scheme with an important and trusted person outside the training
Various Rehearsal: abdominal breathing and relaxation, pacing activities and graded
exercise
8–12 Various Stopping dysfunctional problem solving and replacing it with functional problem-
solving using the five steps of the problem-solving method
(problem attitude, problem definition, alternative solutions, solution plan, and
solution implementation & evaluation)
Rehearsal: abdominal breathing and relaxation, pacing activities and graded
exercise
Session Relapse prevention
13 Summarizing all discussed techniques
Assembling the techniques applicable for own UPS in a personal First Aid kit
Rehearsal: abdominal breathing and relaxation, pacing activities and graded exercise
doi:10.1371/journal.pone.0042629.t001
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one in quick succession and holidays accounting for the only gaps
between one training and another, a randomization list was
usually generated every other 13 weeks.
Randomization—Allocation concealment
As the randomization list was generated after the patients were
assessed for eligibility and enrolled, allocation was certainly
concealed for patients and assessors.
Randomization—Implementation
The randomization list was generated by an investigator who
had no clinical involvement in the trial, and was working in a
different building than the buildings where assessment and
enrollment were done.
Patients were assessed and enrolled by seven psychologists who
had been trained in the SCID-I over several sessions. These
psychologists were not involved in other parts of the study or
patients’ treatment.
Patients were assigned after enrollment according to the
randomization list by a psychologist who was not involved in the
generation of the randomization list, nor in the assessment and
enrollment of patients. Patients were informed about their
assignments by a letter posted to their home address.
Blinding
Patients and trainers could not be blinded for group assignment,
as the control condition was a simple waiting list. The data were
imported and analyzed after patients had completed the trial.
Statistical methods
Effectiveness of the group training. In the randomized
controlled trial the comparability of the patients’ baseline-variables
between patients who completed the randomized controlled trial
and who dropped out were analyzed with the two-tailed t-tests for
independent samples for the continuous variables, with the two-
tailed Mann-Whitney U-tests for the ordinal variables and with the
chi-square tests for the categorical variables. The effects of the
training were analyzed with linear mixed modeling.
Preservation of the effect of the group training. In the
non-randomized, observational follow-up, the comparability of the
patients’ baseline-variables between patients who could be
followed up and who were lost were analyzed with the two-tailed
t-tests for independent samples for the continuous variables, with
the two-tailed Mann-Whitney U-tests for the ordinal variables and
with the chi-square tests for the categorical variables. The
preservation of the effect of the training were analyzed with linear
mixed modeling.
Significance level. All statistical analyses were done with the
significance level fixed at 0.05 (two-tailed).
Results
Participant flow
Figure 2 shows the flow of patients through the study.
Recruitment
Patients were recruited between February 2005 and September
2008 in general practices, in outpatient clinics at general hospitals,
and by our secondary community mental-health service in and
around Rotterdam, the Netherlands. The follow-up ended in
December 2009; one year after the intervention group of the last
randomization had completed the training.
Baseline data
Table 2 and Table 3 list the characteristics of the 162
randomized patients, 133 of whom (82%) provided outcome data.
There were no significant differences between the 133 patients
with primary endpoint outcome data and the 29 who dropped out
the randomized controlled trial with regard to the following: UPS
characteristics, the number of co-morbid DSM-IV axis I and axis
II classifications, referrer characteristics, socio-demographic char-
acteristics, and outcome variables.
Intervention data
In total, the training was conducted 20 times in four different
local medical settings, with between five and nine patients per
intervention (an average of six patients per intervention). The
mean attended sessions in the patients who were randomly
assigned to the training and provided outcome data was eleven.
The minimum number of attended sessions was six.
Each of the 20 groups was led by one of six psychologists with a
Master’s degree, four of whom had had at least three years’ post-
Master’s experience with group therapy and/or cognitive-behav-
ioral therapy. To compensate for their lack of experience of the
other two psychologists, they observed the developer of the manual
(LZ) during a group session before jointly leading another group in
their own session on the following day. (They gave only one 13-
week training.) To increase treatment integrity and positive group
dynamics, all psychologists familiarized themselves with the
tailored consequences model and the manual’s line of reasoning
by going through the manual before each session under the
supervision of LZ.
Numbers analyzed
The statistical analyses were conducted according to the
intention-to-treat principle [50], as the data of all patients who
were randomized were included in the linear mixed modeling.
Outcomes and estimation
Effectiveness of the group training. Table 4 shows the
estimates for the effect of the training on the primary and
secondary endpoints of the randomized controlled trial. The
training had a significant effect on the primary outcome measure
‘Physical component summary’ (p = .002). The effect size was
medium (Cohen’s d = 0.38) according to Cohen’s statistical
guidelines [51]. No effect of the training was found for the
primary outcome measure ‘Mental component summary’. On the
secondary outcome measures of the SF-36, scales in favor of the
training indicating significantly better functioning were ‘Role
functioning physical’ (Cohen’s d= 0.43, p = .01), ‘Bodily pain’
(Cohen’s d = 0.51, p =,.001), ‘Social functioning’ (Cohen’s
d = 0.36, p= .01), and ‘Role functioning emotional’ (Cohen’s
d = 0.44, p = .01). On the secondary measures of the SCL-90-R,
scales in favor of the training indicating a lower number or less
severe symptoms were ‘Somatization’ (Cohen’s d =20.23,
p = 0.05), and ‘Sleep difficulties’ (Cohen’s d=20.25, p= .04).
Preservation of the effect of the group training. Table 5
shows the estimates for the effects of time on the primary and
secondary endpoints of the non-randomized, observational follow-
up. At each time point, time did not eliminate the effects of the
training. In contrary, for the primary outcome measure ‘Physical
component summary’, the effect increased from Cohen’s d 0.39 to
0.49 at three-months follow-up and Cohen’s d was still 0.49 at
one-year follow-up. A similar trend was observed for the secondary
outcome measures ‘Physical functioning’ and ‘Obsessive-compul-
sive’.
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Ancillary analyses
To explore whether patients who had one-year follow-up scores
differed from patients who had no one-year follow-up scores, these
two groups were compared with each other with regard to the
following: UPS characteristics, the number of co-morbid DSM-IV
axis I classifications, referrer characteristics, socio-demographic
characteristics, and outcome variables. Patient with one-year
follow-up scores were significantly older (M=46.69, SD=10.79)
and reported significantly more vitality (M=35.58, SD=17.56),
and significantly less hostility (M=7.99, SD=2.68) than patients
without one-year follow-up scores (age: M=42.44, SD=11.09,
p = .02; SF-36 scale ‘Vitality’: M=29.60, SD=17.88, p = .04, and
SCL-90 scale ‘Hostility’: M=9.53, SD=4.78, p= .03).
Adverse events
One adverse event was reported in this study. After the training,
one patient reported rumination about possible death of beloved
people, which tired her out. For this patient, psychotherapy was
arranged, in which she engaged. Further detailed description of
this patient has been published elsewhere [52].
Discussion
Interpretation
The effect of a cognitive-behavioral group training on the
quality of life was studied in patients with UPS. The training was
based on the consequences model tailored to primary-care patients
and provided by a secondary community mental-health service
reaching out into the primary care. It was found to be effective at
improving the physical domain of quality of life, which was the
domain patients reported as most burdensome at baseline. This
positive effect was preserved during the entire one-year follow-up
period. These results are remarkable, as studies have shown that
the prognosis of UPS becomes more unfavorable if the duration of
UPS is longer [1,53,54,55], or if UPS is classified as a somatoform
disorder [53,56]. In our study group, the median of the duration of
UPS was nine years, and UPS had been classified as undifferen-
tiated somatoform disorder or as chronic pain disorder.
Considering these effects, further research on this training seems
to be worthwhile.
Figure 2. Patient flow. RCT= Randomized Controlled Trial.
doi:10.1371/journal.pone.0042629.g002
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The effects might differ between various subgroups within
patients with UPS. Further research could explore, whether some
subgroups benefit more than others. If the latter is the case,
allocation and selection might improve effectiveness even more.
Also, it would be interesting to explore whether the training also
reduces costs by reducing medical utilization, and productivity
losses due to UPS. This would make the training not only more
interesting from a patient’s but also from a societal’s perspective.
Generalizability
Various terms are used for unexplained physical symptoms.
Examples of other terms used for these symptoms are Medically
Unexplained Physical Symptoms (MUPS), Functional Somatic
Symptoms (FSS), abridged somatization, and multisomatoform
disorder [3,11,57]. The use of different terms and different
definitions makes the communication about these symptoms
between clinicians and researchers within and between disciplines
difficult and reduces generalizability. This might be resolved in the
revision of the American Psychiatric Association’s Diagnostic and
Statistical Manual for Mental Disorders (DSM). Currently, the
proposed revision is to classify this symptoms as Somatic Symptom
Disorder, which is defined as persistent distressing somatic
symptoms in combination with excessive thoughts, feelings, and
behaviors in response to these somatic symptoms [58]. Pending
this revision, we chose among all frequently used terms the term
Unexplained Physical Symptoms (UPS), because this term reflects
best that physical, psychological and social causes and effects are
not or not easily separated from each other, and are mostly
interrelated without a clear starting or finishing point. By using the
term UPS, we acknowledged this interrelationships, promoted
transparency in the communication to all stakeholders; patients,
clinicians and researchers, and followed the recommendation for
Table 2. Patients’ clinical characteristics.
Clinical characteristics Group training (n=84) Waiting list (n =78)
Duration of UPS in years
median 8 9.5
interquartile range 3–16 3–17
Classification of UPS by SCID-I
undifferentiated somatoform disorder 32 31
chronic pain disorder 52 47
Number of comorbid DSM-IV axis I disorders
one or more DSM-IV axis I disorders 38 29
Classification of comorbid DSM-IV axis I disorders
mood disorder (lifetime) 13 (40) 11 (30)
anxiety disorder (lifetime) 20 (36) 27 (41)
substance-related disorder (lifetime) 1 (12) 0 (6)
eating disorder (lifetime) 1 (4) 0 (2)
psychotic disorder (lifetime) 0 (0) 0 (1)
somatization disorder 14 (14) 10 (10)
hypochondriasis 1 (1) 1 (1)
adjustment disorder 2 (2) 2 (2)
Number of comorbid DSM-IV axis II disorders
one or more DSM-IV axis II disorders 26 23
Classification of comorbid DSM-IV axis II disorders
paranoid personality disorder 6 12
schizoid personality disorder 2 3
schizotypal personality disorder 1 1
anti-social personality disorder 0 1
borderline personality disorder 2 5
histrionic personality disorder 1 1
narcissistic personality disorder 0 2
avoidant personality disorder 15 14
dependent personality disorder 2 2
obsessive compulsive personality disorder 14 10
Referrer
primary medical service 41 41
secondary medical service 28 23
secondary mental service 15 14
doi:10.1371/journal.pone.0042629.t002
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terminology on these symptoms, which includes ‘‘to remove
language that is potentially pejorative to patients’’ [11].
The prevalence of having one or more co-morbid DSM-IV Axis
I disorders in our study was 41%. The three most commonly
comorbid DSM-IV axis I disorders were anxiety (29%), mood
(15%), and somatization (15%) disorder. These prevalences are
comparable with earlier findings in patients with UPS. In this
patients’ group, studies found prevalences of comorbid anxiety
and/or depressive disorders in primary care ranging from 26% [2]
to 54% [59]. The prevalence of a comorbid anxiety disorder was
17% and the prevalence of a comorbid depressive disorder was
also 17% [2]. It is known [60], that patients with UPS have a
higher rate of current mood disorder or current anxiety disorder
than either healthy controls or patients with phenomenologically
similar medical diseases of known organic pathology. Including
patients with co-morbid DSM-IV Axis I disorders makes our
results generalizable to a wider group of patients with UPS than is
usually selected for scientific trials, and more similar to the patient
group seen in routine clinical practice.
The prevalence of having one or more personality disorders in
our study was 30%. The three most commonly personality
disorders were avoidant (17.9%), obsessive compulsive (14.8%),
and paranoid (11.1%) personality disorder. These prevalences are
in line with earlier findings in this group of patients. Studies found
prevalences of personality disorders in UPS ranging from 0% to
88.6% [61,62,63,64,65,66,67,68,69,70]. The most commonly
personality disorder for patients with UPS in these studies differed
between obsessive compulsive [61,65,67,68,69], histrionic [62,64],
avoidant [61,70], dependent [67,71] and paranoid [66] person-
ality disorder. Our findings on the prevalence of personality
disorders were quite similar to the rates reported in the study in
patients with chest pain measuring personality disorders using a
self-report questionnaire. This study reported a prevalence of
39%, in which three most commonly reported personality
disorders were obsessive-compulsive (23.3%), avoidant (13.8%),
and paranoid (13.2%) personality disorder [69]. Differences in
prevalences of personality disorders between studies might be
explained by the use of different instruments for the assessment of
personality disorders, but also by the use of different definitions for
unexplained physical symptoms (e.g. somatizing patients and
somatization disorder). As our definition of unexplained physical
symptoms was symptoms fulfilling the DSM-IV criteria for an
undifferentiated somatoform disorder or a chronic pain disorder,
prevalences in our study might also be slightly lower than in
somatoform disorders in general, because studies [61,62] suggested
that both undifferentiated somatoform disorder and chronic pain
disorder were less frequently combined with personality pathology
than the other somatoform disorders. Due to the use of validated
interviews for both the classification of UPS and personality
disorders and comparability of our findings with earlier findings,
we believe our results to be reliable and generalizable.
The training is theory-based and elaborately described in the
manual [38]. It was conducted by six different psychologists with
different experience levels at four different local medical settings.
This suggests that the training is transferable to different
circumstances.
Conducting the training belonged to the daily activities of the
psychologists and was financed within the current reimbursement
practice. By this, the training could be implemented without
research funds. Kathol et al. [72] showed the relevance for this
kind for generalizability, as most evidence-based programs
integrating mental health services in primary care could not be
successfully implemented after completion of the study due to the
Table 3. Patients’ sociodemographic characteristics.
Sociodemographic characteristics Group training (n =84) Waiting list (n =78)
Gender
female 67 64
male 17 14
Age in years
mean 46 44
interquartile range 38–53 35–52
Nationality
Dutch 72 69
other 12 9
Marital status
married/living with partner 62 48
unmarried/divorced/widowed 22 30
Highest education completed
primary school or less 7 7
lower vocational or general secondary education 29 25
intermediate vocational or higher general secondary education 33 24
higher vocational, pre-university, or university education 15 21
missing 0 1
Employment
employment 29 28
no employment 55 50
doi:10.1371/journal.pone.0042629.t003
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fact that research funds were not substituted within the current
reimbursement practice.
Limitations
The options for the study were limited by the fact that it was
part of daily activities of a secondary community mental-health
service. Because patients on the waiting list had to wait only 13
weeks for the group training – the same period as the training itself
– the study was deprived of a control condition for the three-
month and one-year follow-ups. However, our time frame of
follow-up assessments was longer than the usual time frame of
intervention studies for UPS that ranged from three to 12 months
with a mean of six months [18].
Not only the length of the control condition for the influence of
time and other not-intervention-related circumstances, but also the
lack of a control condition for the influence of intervention-related
aspects was a limitation. Because of this limitation, the measured
effects could not be attributed to the specific therapeutic
interventions of our training. If a control intervention group (e.g.
relaxation, solely psycho-education, self help, individual treatment)
had been included, it would have been possible to explore whether
the training itself had supplementary effects in comparison to other
interventions or individual treatment.
Another limitation of our study is that inter-rater-reliability was
not calculated for the Structured Clinical Interview for DSM-IV Axis I
Disorders (SCID-I), which verified whether patients fulfilled the
inclusion criteria for undifferentiated somatoform disorder or
chronic pain disorder. This is especially regrettable, as the number
of UPS classified as undifferentiated somatoform disorder was
lower than the number of UPS classified as chronic pain disorder –
the opposite of what was found in a study in Dutch general
practices [2]. To clarify this difference, we examined the SCID-I
interviews more closely. This showed that, due to the interviewers’
or patients’ emphasis on pain in the presence of a broad spectrum
of symptoms, syndromes such as fibromyalgia or chronic fatigue
syndrome had sometimes been misclassified as chronic pain
disorder. These misclassifications might have inflated the number
of chronic pain disorders at the expense of undifferentiated
somatoform disorder.
Not only the comparability of interviews, but also the
comparability of the training’s sessions in different groups was
not measured. As supervision was given by the developer of the
manual (LZ) before each session, treatment integrity and
comparability were stimulated but they were not verified. If the
group sessions had been recorded, they could have been rated by
independent raters and treatment integrity could have been
verified.
Randomization was used to reach comparability between the
patients in the training and patients on the waiting list. Notably,
this randomization resulted in an imbalance of distribution of
Table 4. Estimates for training and waiting group.
Scale Intercept Time Time* Training Training vs. Waiting groep
Primary endpoint Estimate [95% CI] Estimate [95% CI] Estimate [95% CI] Cohen’s d p
SF-36 scale
physical component summary 31.2 [30.1–32.8] 1.5 [0.04–3.01] 3.4 [1.3–5.5] 0.38 0.002
mental component summary 45.2 [43.5–46.7]
Secondary endpoint
SF-36 scale
physical functioning 50.9 [47.1–54.6] 2.2 [21.3–5.6] 4.7 [20.3–9.7] 0.19 0.06
role functioning physical 15.6 [11.4–19.8] 5.9 [20.3–12.1] 11.7 [2.6–20.7] 0.43 0.01
bodily pain 33.2 [30.3–36.2] 0.3 [23.4–3.9] 9.9 [4.8–15.1] 0.51 ,0.001
general health 38.0 [35.2–40.7] 3.8 [1.3–6.4]
vitality 33.4 [3.06–36.2] 3.4 [20.4–7.3] 5.4 [0.1–10.7] 0.30 0.05
social functioning 49.2 [45.4–52.9] 1.6 [23.3–6.6] 8.6 [1.7–15.5] 0.36 0.01
role functioning emotional 72.1 [62.7–81.5] 210.1 [220.3–0.11] 18.4 [3.4–33.3] 0.44 0.01
(training group baseline1) 213.4 [226.5–20.4])
mental health 62.0 [60.1–65.9]
SCL-90-R scale
phobic anxiety 9.2 [8.6–9.8]
anxiety 17.6 [16.5–18.7]
depression 31.7 [30.0–33.5] 21.9 [23.4–20.5]
somatization 29.2 [27.8–30.5] 22.0 [22.6–0.2] 22.0 [24.0–0.0] 20.23 0.05
obsessive-compulsive 20.7 [19.7–21.7] 21.2 [22.1–20.4]
interpersonal sensitivity 26.7 [25.2–28.2]
hostility 8.5 [8.0–9.0]
sleep difficulties 8.0 [7.5–8.6] 20.4 [21.0–0.2] 20.9 [21.8–0.0] 20.25 0.04
global severity index 165.5 [158.0–173.0] 28.1 [213.3–22.8]
Note: Insignificant effects are not presented in this table.
1)Role functioning at baseline was different between training and waiting group.
doi:10.1371/journal.pone.0042629.t004
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living with or without a partner over the training and the waiting
group, although this imbalance was not significant (p = .13).
Nevertheless, such imbalance might have influenced the results in
favor of the training, as this demographic variable could be seen as
in indicator of social support and the ability to have stable
relationships.
Overall evidence
Earlier studies have found that cognitive-behavioral therapy
improved physical symptoms, psychological distress, and function-
al status [14,15]. The effect sizes for this therapy compared to
control conditions centered around .40 [14]. Physical symptoms
appeared to be the most responsive [14,15], although in some
studies for specific syndromes, such as chronic fatigue syndrome
and fibromyalgia, the opposite was found, and the effect size for
psychological distress was larger [14]. Improvement of the physical
symptoms could occur whether or not psychological distress was
decreased [73]. Preservation of positive effects was observed in 6-
months to one-year follow-up assessments [14].
Our findings seemed to be consistent with these earlier studies
as they showed a similar improvement of functional status and
symptoms, more responsiveness of physical symptoms in compar-
ison to psychological symptoms, and the preservation of these
effects over the one-year follow-up period. The effect size of .38 in
the randomized controlled trial and the effect size of .49 in the
non-randomized one-year follow-up might even be considered to
be relatively high, because our training was designed to be easily
accessible, and, thereby, might have included more patients with
higher resistance to psychological interventions.
For this, the tailoring of the consequences model for primary-
care patients might have been essential. It was only after doing so
that we discovered that, due to low acceptance [74], and no
effectiveness [27], two previous attempts to use the original
consequences model in primary care had failed. Although most
patients in our study had been referred by medical services,
especially by general practitioners, ‘only’ 78 of the 269 (29%)
patients did not attend the first appointments (so-called ‘no
shows’); this no-show figure was substantially lower than the
estimated 50%–80% of patients who refuse to be referred to
mental-health services [20]. Patients also seemed to accept the
training itself: 65 of the 84 who were randomized to it (77%), and
52 of the 72 who waited for it (72%) really attended the training.
By seeking close collaboration with medical centers and offering
treatment at their centers, we might not only have broadened the
accessibility of mental-health services for primary-care patients. As
physicians rated the problems of getting mental health services for
their patients twice as high as the problems of getting other
specialty services [19], we might also have simplified the access of
mental-health services for physicians.
The success rate of referrals from medical care services to the
training might still be improvable. The three most common
reasons for failure to seek treatment after referral are 1.) the
problem has resolved, 2.) patients need to wait before treatment
starts, and 3.) a lack of motivation [44]. With regard to the first
reason, it is suggested by the long duration of UPS in our patients,
and also by the overall low recovery rate in patients with
somatoform disorders [56], that the problem had not resolved. But
the second reason – having to wait for treatment – was certainly an
issue: those who had to wait, such as those on the waiting list,
complained about it. Indeed, some could not bring themselves to
wait and left the trial. Therefore, if this training is implemented in
routine clinical practice, a short waiting period before treatment
starts is advisable. The third reason – lack of motivation to
actualize the referral – revealed another area in which there is
scope for further improvement. Patients commented that their
physicians had suggested that their complaints were ‘all in their
heads’. In certain cases, the sense of not being taken seriously
made them delay seeking treatment and made them express anger
about it at their first appointment. Feeling disrespected is a factor
that is known to influence un-notified no-shows [75].
Perhaps the number of successful referrals might be increased if
physicians are trained to use the language of the tailored
consequences model to explain the goals of the referral and the
treatment – without having to do the cognitive-behavioral
interventions themselves. Asking them to do these interventions
themselves might not be as effective because of the implementation
issues mentioned in the introduction, but also because of difference
in education between physicians and psychologists, and the low
volume of doing psychological treatment for general practitioners
in comparison to psychologists. In medicine, it is a well-established
fact, that outcomes raise with higher volumes [76].
In short, the cognitive-behavioral group training tailored for
UPS in primary care and provided by an outreaching secondary
mental-health service appears to be effective and to broaden the
accessibility of the treatment of UPS.
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